Facts of Navelbine ®(Vinorelbine Tartrate) ?
- Medicine Name: Navelbine®
- Generic Name: Vinorelbine Tartrate
- Approval Date: 6/8/2000
- Company Name: GlaxoSmithKline.
- Available as (Form & Strength): Injection: 40 mg/4 mL and 100 mg/10 mL solution in a single-use vial.
What are the indications and usage?
NAVELBINE is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with Stage IV NSCLC, NAVELBINE is indicated as a single agent or in combination with cisplatin. In Stage III NSCLC, NAVELBINE is indicated in combination with cisplatin.[/vc_column_text][/vc_column][/vc_row]